Report - Acrux (ASX: ACR) · 2013-02-17 · AXIRON OUTLOOK FOR 2013 • Continuing US market growth – Transdermal prescriptions in January 2013 were ~18% higher than January 2012 • US

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form